Trieb K, Göggel M, Dürr H-R
Abteilung für Orthopädie, Klinikum Wels-Grieskirchen, Grieskirchnerstr. 42, 4600, Wels, Österreich.
Oper Orthop Traumatol. 2012 Jul;24(3):263-9. doi: 10.1007/s00064-011-0139-2.
Technique for limb-salvage surgery of tumors of the proximal tibia. Endoprosthetic replacement of the tibia with a modular tumor endoprosthesis and reconstruction of the extensor mechanism with a gastrocnemius flap.
Primary tumors and recurrences of semimalignant tumors of the proximal tibia. Diagnosis by biopsy and, depending on the entity, neoadjuvant chemotherapy.
Tumor infiltration of nerves or vessels, massive soft tissue infiltration, pathologic fracture, superinfection.
The tumor is resected en bloc with wide margins including the biopsy scar, the knee joint is resected intra-extra articular, politeal structures are exposed (anatomical border to the tumor is the popliteus muscle), osteotomy of the tibia 3-5 cm distal of the tumor. After removing the tumor, reconstruction with a modular tumor endoprosthesis is performed. The medial gastrocnemius muscle is detached and mobilized, rotated anteriorly and connected to the patella tendon. Closure of the muscle and skin.
Suction drainage for 48 h, extension brace for 2 weeks, followed by partial weight-bearing for 6 weeks.
Despite technical developments over the years, a complication rate > 10% remains. Secondary amputation due to local recurrence is reported in about 10% of cases and due to infection in 6-12%. Transient or permanent palsy of the peroneal nerve is observed in 5% of cases. A quarter of all patients have full (< 20° extension lag) active extension, the mean extension lag is about 30°. The probability of a revision (including implant related) is 60-70% after 10 years. Based on the clinical results, the technical demanding resection of the proximal tibia is a recommendable procedure.
胫骨近端肿瘤保肢手术技术。采用模块化肿瘤假体进行胫骨置换,并利用腓肠肌瓣重建伸肌机制。
胫骨近端半恶性肿瘤的原发性肿瘤及复发肿瘤。通过活检进行诊断,并根据具体情况进行新辅助化疗。
肿瘤侵犯神经或血管、大量软组织浸润、病理性骨折、严重感染。
将肿瘤连同活检瘢痕一并整块切除,在关节内外联合切除膝关节,暴露腘部结构(肿瘤的解剖边界为腘肌),在肿瘤远端3 - 5厘米处截断胫骨。切除肿瘤后,使用模块化肿瘤假体进行重建。分离并游离内侧腓肠肌,向前旋转并与髌腱相连。缝合肌肉和皮肤。
持续48小时负压引流,佩戴伸直支具2周,随后部分负重6周。
尽管多年来技术有所发展,但并发症发生率仍>10%。约10%的病例因局部复发而进行二期截肢,6 - 12%的病例因感染而截肢。5%的病例观察到腓总神经出现短暂或永久性麻痹。四分之一的患者主动伸直完全正常(伸直滞后<20°),平均伸直滞后约为30°。10年后翻修(包括与植入物相关的翻修)的概率为60 - 70%。基于临床结果,对胫骨近端进行技术要求较高的切除是一种值得推荐的手术方法。